These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 31166382)
1. Downregulation of lncRNA CCDC26 contributes to imatinib resistance in human gastrointestinal stromal tumors through IGF-1R upregulation. Yan J; Chen D; Chen X; Sun X; Dong Q; Hu C; Zhou F; Chen W Braz J Med Biol Res; 2019; 52(6):e8399. PubMed ID: 31166382 [TBL] [Abstract][Full Text] [Related]
2. CCDC26 knockdown enhances resistance of gastrointestinal stromal tumor cells to imatinib by interacting with c-KIT. Cao K; Li M; Miao J; Lu X; Kang X; Zhu H; Du S; Li X; Zhang Q; Guan W; Dong Y; Xia X Am J Transl Res; 2018; 10(1):274-282. PubMed ID: 29423012 [TBL] [Abstract][Full Text] [Related]
3. LncRNA-HOTAIR activates autophagy and promotes the imatinib resistance of gastrointestinal stromal tumor cells through a mechanism involving the miR-130a/ATG2B pathway. Zhang J; Chen K; Tang Y; Luan X; Zheng X; Lu X; Mao J; Hu L; Zhang S; Zhang X; Chen W Cell Death Dis; 2021 Apr; 12(4):367. PubMed ID: 33824300 [TBL] [Abstract][Full Text] [Related]
5. miR-125a-5p regulation increases phosphorylation of FAK that contributes to imatinib resistance in gastrointestinal stromal tumors. Huang WK; Akçakaya P; Gangaev A; Lee L; Zeljic K; Hajeri P; Berglund E; Ghaderi M; Åhlén J; Bränström R; Larsson C; Lui WO Exp Cell Res; 2018 Oct; 371(1):287-296. PubMed ID: 30149002 [TBL] [Abstract][Full Text] [Related]
6. KIT over-expression by p55PIK-PI3K leads to Imatinib-resistance in patients with gastrointestinal stromal tumors. Lai S; Wang G; Cao X; Luo X; Wang G; Xia X; Hu J; Wang J Oncotarget; 2016 Jan; 7(2):1367-79. PubMed ID: 26587973 [TBL] [Abstract][Full Text] [Related]
7. SOCS1 gene therapy has antitumor effects in imatinib-resistant gastrointestinal stromal tumor cells through FAK/PI3 K signaling. Sugase T; Takahashi T; Serada S; Fujimoto M; Ohkawara T; Hiramatsu K; Nishida T; Hirota S; Saito Y; Tanaka K; Miyazaki Y; Makino T; Kurokawa Y; Yamasaki M; Nakajima K; Hanasaki K; Kishimoto T; Mori M; Doki Y; Naka T Gastric Cancer; 2018 Nov; 21(6):968-976. PubMed ID: 29623544 [TBL] [Abstract][Full Text] [Related]
8. Hedgehog pathway dysregulation contributes to the pathogenesis of human gastrointestinal stromal tumors via GLI-mediated activation of KIT expression. Tang CM; Lee TE; Syed SA; Burgoyne AM; Leonard SY; Gao F; Chan JC; Shi E; Chmielecki J; Morosini D; Wang K; Ross JS; Kendrick ML; Bardsley MR; Siena M; Mao J; Harismendy O; Ordog T; Sicklick JK Oncotarget; 2016 Nov; 7(48):78226-78241. PubMed ID: 27793025 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways. Xu Y; Huang J; Ma L; Shan J; Shen J; Yang Z; Liu L; Luo Y; Yao C; Qian C Cancer Lett; 2016 Feb; 371(2):171-81. PubMed ID: 26655273 [TBL] [Abstract][Full Text] [Related]
10. FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors. Li F; Huynh H; Li X; Ruddy DA; Wang Y; Ong R; Chow P; Qiu S; Tam A; Rakiec DP; Schlegel R; Monahan JE; Huang A Cancer Discov; 2015 Apr; 5(4):438-51. PubMed ID: 25673643 [TBL] [Abstract][Full Text] [Related]
11. The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cells. Wang H; Li Q; Tang S; Li M; Feng A; Qin L; Liu Z; Wang X Hematology; 2017 May; 22(4):208-216. PubMed ID: 27875938 [TBL] [Abstract][Full Text] [Related]
13. Novel lncRNA-IUR suppresses Bcr-Abl-induced tumorigenesis through regulation of STAT5-CD71 pathway. Wang X; Yang J; Guo G; Feng R; Chen K; Liao Y; Zhang L; Sun L; Huang S; Chen JL Mol Cancer; 2019 Apr; 18(1):84. PubMed ID: 30961617 [TBL] [Abstract][Full Text] [Related]
14. LncRNA HIF1A-AS2 mediates imatinib resistance by regulating autophagy in gastrointestinal stromal tumor cells. Yan J; Chen X; Lin J; Sun X; Chen W Neoplasma; 2023 Aug; 70(4):526-533. PubMed ID: 37789783 [TBL] [Abstract][Full Text] [Related]
15. The novel pyrrolo-1,5-benzoxazepine, PBOX-15, synergistically enhances the apoptotic efficacy of imatinib in gastrointestinal stromal tumours; suggested mechanism of action of PBOX-15. Kinsella P; Greene LM; Bright SA; Pollock JK; Butini S; Campiani G; Bauer S; Williams DC; Zisterer DM Invest New Drugs; 2016 Apr; 34(2):159-67. PubMed ID: 26885657 [TBL] [Abstract][Full Text] [Related]
16. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression. Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway. Guo A; Fang G; Lin Z; Zheng S; Zhuang Z; Lin R; Lin Y Histol Histopathol; 2022 Jun; 37(6):543-554. PubMed ID: 35102541 [TBL] [Abstract][Full Text] [Related]
18. Dual Targeting of Insulin Receptor and KIT in Imatinib-Resistant Gastrointestinal Stromal Tumors. Chen W; Kuang Y; Qiu HB; Cao Z; Tu Y; Sheng Q; Eilers G; He Q; Li HL; Zhu M; Wang Y; Zhang R; Wu Y; Meng F; Fletcher JA; Ou WB Cancer Res; 2017 Sep; 77(18):5107-5117. PubMed ID: 28760855 [TBL] [Abstract][Full Text] [Related]